DOJ Alleges Kickbacks in Medicare Advantage Broker Commissions
The DOJ files a lawsuit accusing insurers and brokerages of illicit kickbacks in Medicare Advantage plan enrollments, raising compliance and regulatory concerns.
UnitedHealthcare Ends Commissions on Medicare Drug Plans Amid Rising Costs
UnitedHealthcare stops paying commissions on Medicare prescription drug plans sold after June 1, 2025, impacting agents amid rising Medicare Advantage costs and prompting calls for CMS intervention.
New Bill Proposes Medicare Copay Cap for Ambulatory Surgical Centers
Bipartisan legislation aims to cap Medicare coinsurance costs for services at ambulatory surgical centers, promoting cost-effective healthcare and reducing patient expenses.
CMS Administrator Dr. Mehmet Oz Highlights Commitment to Medicare and Medicaid Efficiency
CMS Administrator Dr. Mehmet Oz emphasizes protecting Medicare and Medicaid beneficiaries, targeting fraud, waste, and abuse, and promoting healthy living initiatives under new CMS leadership.
UnitedHealth Faces Challenges but Insiders Signal Confidence with Strategic Stock Buys
UnitedHealth’s stock rebounds amid DOJ probe and leadership stock purchases, reflecting market dynamics in healthcare, regulatory challenges, and sector shifts.
Impact of Proposed Medicaid and Medicare Cuts on U.S. Coverage and Care
Explore how proposed $880B federal cuts to Medicaid and Medicare could reduce coverage for millions, affecting quality of care and access to critical health services across the U.S.
Navigating Evolving Vaccine Policies and Medicare Billing Compliance
Explore critical regulatory updates and compliance strategies for healthcare providers navigating evolving vaccine policies and Medicare billing rules. Learn from expert legal and clinical insights to manage outbreak risks and optimize revenue cycle operations.
UnitedHealth Group Shares Plunge Amid DOJ Medicare Fraud Investigation
UnitedHealth Group faces a DOJ investigation for possible Medicare fraud, leading to its worst monthly stock slump and raising regulatory and market concerns in the U.S. health insurance sector.
2025 Marks Key Anniversaries for Social Security, Medicare, Medicaid, ADA, and ACA
Explore the 2025 anniversaries of foundational U.S. laws: Social Security, Medicare, Medicaid, ADA, and ACA, highlighting their impact on insurance regulation and healthcare policy.
Inflation Reduction Act Expected to Lower Medicare Part D Out-of-Pocket Costs for Specialty Drugs
New analysis shows Inflation Reduction Act provisions will reduce Medicare Part D out-of-pocket costs for specialty drugs etanercept, ustekinumab, and ibrutinib, improving affordability for beneficiaries.